Developers: | apoQlar |
Date of the premiere of the system: | Dec 2022 |
Branches: | Pharmaceuticals, Medicine, Healthcare |
System announcement
On December 5, 2022, the company apoQlar announced the release of a surgical planning system with help ON mixed reality called VSI HoloMedicine.
According to the developers, the system provides surgeons with the ability to plan complex procedures using 3D holographic technology. According to a press release, the company intends to distribute products in the United States through its Miami subsidiary. With this being apoQlar's latest achievement in terms of global expansion and serving as a tailwind for further market expansion efforts in Southeast Asia, India and Gulf Coast countries, the company added.
{{quote 'Thanks to mixed reality, we are no longer tied to physical objects in the physical world! We can use digital objects and services on top of the real world to achieve equal or greater utility and, as a rule, at a lower cost. Mixed reality is a completely new way for people, and in our case for surgeons, doctors and technologists, to continue to perceive the real world around them, but with a whole virtual layer on top of it, "said apoQlar co-founder and CEO Sirko Pelzl. }} apoQlar intends to conduct a Series A funding round. This is the first ever apoQlar campaign to raise funds for the development of VSI HoloMedicine. The company said its system gives surgeons something akin to "X-ray vision" when planning operations.
The HoloMedicine VSI device uses 3D holographic technology to allow surgeons to visualize medical data in or outside the operating room. The system uses Microsoft's HoloLens 2 mixed reality display. Surgeons can convert flat CT, angio CT, MRI, CBCT, PET and SPECT into interactive 3D holograms. According to the developers, this improves the overall planning process for surgeons.[1]